Lyra Therapeutics (LYRA) Stock Highlights

0.52 | -87.1%

2024-05-07 02:55:52

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The companys technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Statistics

Range Today

0.36 0.64

Volume Today 108.36M

Range 1 Year

2.36 6.79

Volume 1 Year 73.08M

Range 3 Year

1.86 9.98

Volume 3 Year 115.47M

Range 10 Year

1.86 22

Volume 10 Year 145.71M

Highlights

Market Capitalization 281.05M (small)

Floating Shares 26.76M

Current Price 0.52

Price To Earnings -3.98

Price To Revenue 116.92

Price To Book 3.17

Earnings Per Share -1.17

Payout Ratio 0%

Performance

Latest -87.1%

1 Month -89.64%

3 Months -89.49%

6 Months -83.7%

1 Year -80%

3 Years -93.73%

5 Years -97.64%

10 Years -97.64%

Benchmarks

Market Capitalization

206 / 368

Gross Profits

183 / 278

Total Revenue

229 / 300

Total Rank

187 / 368

Free Cashflow

161 / 352

Performance 5 years

265 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.